Detalhe da pesquisa
1.
Reversible Conformational Change in the Plasmodium falciparum Circumsporozoite Protein Masks Its Adhesion Domains.
Infect Immun
; 83(10): 3771-80, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26169272
2.
mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune response.
NPJ Vaccines
; 9(1): 9, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184666
3.
Preclinical evaluations of Pfs25-EPA and Pfs230D1-EPA in AS01 for a vaccine to reduce malaria transmission.
iScience
; 26(7): 107192, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37485364
4.
Structural and immunological differences in Plasmodium falciparum sexual stage transmission-blocking vaccines comprised of Pfs25-EPA nanoparticles.
NPJ Vaccines
; 8(1): 56, 2023 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061547
5.
Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA.
Lab Anim (NY)
; 52(12): 315-323, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37932470
6.
Malaria transmission-blocking vaccines Pfs230D1-EPA and Pfs25-EPA in Alhydrogel in healthy Malian adults; a phase 1, randomised, controlled trial.
Lancet Infect Dis
; 23(11): 1266-1279, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37499679
7.
Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines.
iScience
; 25(8): 104739, 2022 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846379
8.
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.
Lancet Infect Dis
; 22(3): 377-389, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34801112
9.
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques.
NPJ Vaccines
; 6(1): 148, 2021 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34887448
10.
Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not mice.
J Clin Invest
; 131(7)2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33561016
11.
Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230.
Vaccine
; 38(34): 5480-5489, 2020 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32600913
12.
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults.
Lancet Infect Dis
; 18(9): 969-982, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061051
13.
Determination of Protein Content in Alhydrogel®-Based Vaccines by O-Phthalaldehyde Assay.
Methods Mol Biol
; 1494: 263-271, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27718200
14.
Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresis.
Ther Adv Vaccines
; 5(2): 31-38, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515938
15.
Identification of Protective B-Cell Epitopes within the Novel Malaria Vaccine Candidate Plasmodium falciparum Schizont Egress Antigen 1.
Clin Vaccine Immunol
; 24(7)2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468980
16.
Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicity.
PLoS One
; 12(12): e0190312, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29281708
17.
A Method for Producing Protein Nanoparticles with Applications in Vaccines.
PLoS One
; 11(3): e0138761, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26950441
18.
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.
PLoS One
; 11(10): e0163144, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27749907
19.
Development of a Pfs25-EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle.
Vaccine
; 31(28): 2954-62, 2013 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23623858
20.
Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.
Vaccine
; 30(2): 189-94, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22107848